Bethyl Laboratories
Purified Recombinant Human IgA2, kappaNew
Antigen Proteins
Catalog #P80-007
ClonalityRecombinant Monoclonal
ApplicationELISA
Image 1 of 3
local_shipping
Order within 18 hours and 0 minutes for shipment by Tuesday, November 24
Product Description
IgA is an immunoglobulin that is typically dimeric and held together by a J-chain protein. IgA is typically found near the mucous membranes of the body, including the gut, respiratory system, eyes, and colostrum. Also exists in a secretory form (in mucosal regions) vs. serum IgA, which is found in serum. IgA exists in two subclasses, IgA1 and IgA2, both of which are essential components of mucosal immunity. Although they share similar immune functions, they differ in structure, distribution, and vulnerability to proteolytic enzymes. IgA1 is the main form found in the bloodstream, while IgA2 is more commonly present in secretions such as saliva, tears, and breast milk.
Specifications
Clonality
Recombinant Monoclonal
Isotype
IgA2, kappa
Species
Human
Format
Whole IgA
Epitope Tag
None
Conjugate Type
Unconjugated
Purity
Purified
Concentration
1 mg/ml
Product Information
Applications
ELISA
Buffer
Phosphate Buffered Saline (PBS) with 0.09% Sodium Azide, BSA-Free
Storage Conditions
2 - 8 °C
Physical State
Liquid
Shelf Life
1 year from date of receipt
Country of Origin
USA
Production & Epitope
Antibody variable sequence derived from human anti CoV Spike antibody CR3022 (PMID: 32065055).
Antibody was produced by transient transfection in CHO cells.
Recombinant antibody was purified from cell culture supernatant using and affinity based immunosorbent.
Applications
Used as a positive control in immunoassays.
Documents
Safety Data SheetPDF · P80-007Open
Product DatasheetPDF · P80-007 · Lot PX240926A (current lot)Open
Services
Antibody Conjugation
Antibody and conjugate formats developed together, built to your specification.
Request CustomizationCustom Monoclonal Antibody Discovery Services
Full custom monoclonal development, from immunization through validation.
Explore Monoclonal DevelopmentVHH Discovery
Single-domain antibodies for structurally difficult targets a conventional monoclonal can't reach.
Explore VHH DiscoveryResources
1



